Cytek Biosciences, Inc.

NASDAQ:CTKB

4.02 (USD) • At close September 5, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 75.4795.29898.716162.272177.918169.141167.63163.629131.544129.476296.601341.523349.894362.506364.618376.771159.846168.584165.231-30.122
Short Term Investments 186.552170.314179.145115.50599.323101.29895.111124.392167.294169.51944.5480000000060.244
Cash and Short Term Investments 262.022265.612277.861277.777277.241270.439262.741288.021298.838298.995341.149341.523349.894362.506364.618376.771159.846168.584165.23130.122
Net Receivables 56.23255.20760.58852.63444.75250.37256.1255.40252.09943.150.87540.00837.18332.00229.7629.4524.02915.51316.990
Inventory 49.48745.34743.89346.850.0754.74260.87766.87565.73169.50248.15449.36945.34537.98232.17127.51126.65526.21823.0180
Other Current Assets 15.08414.33514.10412.9812.05113.09412.65311.4588.15316.78613.84212.95910.8486.6225.3116.0946.4082.2223.3830
Total Current Assets 382.825380.501396.446390.191384.084388.647392.06422.315424.821425.622454.02443.859443.27439.112432.052439.826216.938212.537208.62230.122
Non-Current Assets:
Property, Plant & Equipment, Net 34.73927.70228.1328.63227.44228.19629.25829.11828.01128.73627.56522.2620.97520.3435.8514.9823.8952.4762.140
Goodwill 16.70716.67816.66316.18316.18316.18316.18316.45719.14319.04310.14410.14410.14410.14410.1440.4760.4760.4760.4760
Intangible Assets 18.60119.43120.12820.49221.4222.25223.08424.29223.68324.7644.3314.4853.8594.3284.7390.3610.3330.2740.2740
Goodwill and Intangible Assets 35.30836.10936.79136.67537.60338.43539.26740.74942.82643.80714.47514.62914.00314.47214.8830.8370.8090.750.750
Long Term Investments 00001.61.61.61.61.61.601.600000000
Tax Assets 35.76533.70933.37430.77829.67632.70833.69924.0826.38723.40420.45913.98811.68910.6889.2497.3787.3787.3787.3780
Other Non-Current Assets 4.6834.5744.7594.953.322.4811.7851.5681.4091.4062.9572.9592.881.2641.6651.2971.2591.1231.089-30.122
Total Non-Current Assets 110.495102.094103.054101.03599.641103.42105.60997.115100.23398.95365.45655.43649.54746.76731.64814.49413.34111.72711.357-30.122
Total Assets 493.32482.596499.5491.226483.725492.067497.669519.43525.054524.575519.476499.295492.817485.879463.7454.32230.279224.264219.9790
Liabilities & Equity:
Current Liabilities:
Account Payables 6.8536.2475.5295.3893.1913.7253.0324.7113.0825.284.8055.646.7495.9713.0343.9273.3243.3612.9440
Short Term Debt 07.5318.414012.3094.21814.32812.8933.4923.5853.5111.4132.5292.2140002.7722.7720
Tax Payables 04.1093.5591.7380.3580.721.2972.2132.1661.9751.6671.1491.2914.0623.8791.1420.9530.9681.0340
Deferred Revenue 28.12828.74925.49225.36523.96823.00922.69523.04722.1518.10414.54113.1229.99113.4187.0815.8854.6683.5224.2890
Other Current Liabilities 38.28921.05516.9230.30522.45546.90326.75825.84344.85127.57324.51633.29221.7930.55618.16924.94523.88817.14119.7860
Total Current Liabilities 73.2767.69167.66362.79752.37955.56656.22658.69353.59156.51749.0441.49442.3542.80332.1629.83928.16527.76426.5360
Non-Current Liabilities:
Long Term Debt 14.1198.3668.6028.99217.55610.17420.60611.87512.71513.67414.58314.32612.31612.684000000
Deferred Revenue Non-Current 015.717014.78714.06415.16415.13214.95816.05413.01213.12410.40711.027.1999.797.7416.3175.3613.4560
Deferred Tax Liabilities Non-Current 00008.1138.6973.212000013.988009.17300000
Other Non-Current Liabilities 28.37411.19927.49819.18710.60318.5499.42918.3818.51517.91217.18316.55916.00215.75114.94913.3712.463205.896206.0150
Total Non-Current Liabilities 42.49335.28236.142.96642.22343.88748.37945.21347.28444.59844.8941.29239.33835.63424.73921.111213.099211.257209.4710
Total Liabilities 115.763102.973103.763105.76394.60299.453104.605103.906100.875101.11593.9382.78681.68878.43756.89950.95241.264239.021236.0070
Equity:
Preferred Stock 00000000000499.295492.817485.8790454.32194.319194.319194.31974.653
Common Stock 0.1270.1280.1290.130.1320.1310.1310.1360.1360.1360.1350.1350.1350.1340.1260.1250.0240.0240.0230
Retained Earnings -52.184-46.601-35.199-44.84-45.781-35.347-29.178-34.681-28.225-23.837-17.03-20.559-22.225-21.627-18.19-18.24-19.835-22.505-22.6070
Accumulated Other Comprehensive Income/Loss -0.038-0.6090.0160.101-0.195-1.554-1.275-1.579-1.759-0.587-0.697-0.530.2280.9110.8970.570.5360.2670.065-41.701
Other Total Stockholders Equity 429.652426.705430.791430.072434.967429.384423.386451.648454.027447.748442.887437.401432.889427.818423.625420.6-186.344-194.319-194.3190
Total Shareholders Equity 377.557379.623395.737385.463389.123392.614393.064415.524424.179423.46425.295416.447411.027407.236406.458403.055-11.3-15.072-16.02832.952
Total Equity 377.557379.623395.737385.463389.123392.614393.064415.524424.179423.46425.546416.509411.129407.442406.801403.37-10.985-14.757-16.02832.952
Total Liabilities & Shareholders Equity 493.32482.596499.5491.226483.725492.067497.669519.43525.054524.575519.476499.295492.817485.879463.7454.32230.279224.264219.97932.952